Enlivex ENLV
NASDAQ ENLV
$1.04 -0.07 (-6.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

Enlivex (ENLV) Cost of Revenue (2022 - 2025)

Enlivex (ENLV) posted Cost of Revenue of $2.2 million for Q3 2025, up 18.04% on a QoQ basis from $1.9 million in Q2 2025, and down 15.26% year-over-year from $2.6 million in Q3 2024.

Analysis

Enlivex (ENLV) Cost of Revenue (2022 - 2025) Analysis & Trends

Enlivex has reported Cost of Revenue for 4 years, with the latest figure at $2.2 million in Q3 2025.

  • On a quarterly basis, Cost of Revenue fell 15.26% year-over-year to $2.2 million in Q3 2025; TTM through Sep 2025 was $10.1 million, a 35.91% decrease from a year earlier, with the FY2022 full-year figure at $2.0 million, up 35.81% from the prior year.
  • Cost of Revenue was $2.2 million for Q3 2025 at Enlivex, up from $1.9 million in the prior quarter.
  • The five-year high for Cost of Revenue was $9.9 million in Q2 2022, with the low at -$21.8 million in Q4 2022.
  • Average Cost of Revenue over 4 years is $3.0 million, with a median of $4.1 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Cost of Revenue advanced 4.01% in 2023, then sank 56.36% in 2024.
  • Over 4 years, Cost of Revenue stood at -$21.8 million in 2022, then soared by 127.32% to $6.0 million in 2023, then tumbled by 56.36% to $2.6 million in 2024, then declined by 15.26% to $2.2 million in 2025.
  • The last three Cost of Revenue figures came in at $2.2 million (Q3 2025), $1.9 million (Q2 2025), and $3.5 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.81 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.58 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 489.20 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 360.70 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 145.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 93.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 298.26 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 776.90 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 284,000.00
10 Enlivex 3.17 Mn -2.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.21 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 3.45 Mn
Sep 30, 2024 2.60 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 4.14 Mn
Sep 30, 2023 5.96 Mn
Jun 30, 2023 6.79 Mn
Mar 31, 2023 7.22 Mn
Dec 31, 2022 -21.83 Mn
Sep 30, 2022 5.73 Mn
Jun 30, 2022 9.91 Mn
Mar 31, 2022 8.23 Mn